I flere end halvdelen af de meddelte tilfælde fortsattes behandlingen med proteasehæmmere eller behandlingen blev genoptaget, hvis behandlingen var seponeret.
In more than half of the reported cases, treatment with protease inhibitors was continued or reintroduced if treatment had been discontinued.